Kruse, C. http://orcid.org/0000-0001-5590-2245
Goemaere, S.
De Buyser, S.
Lapauw, B.
Eiken, P.
Vestergaard, P.
Article History
Received: 16 July 2017
Accepted: 25 February 2018
First Online: 22 March 2018
Compliance with ethical standards
:
: CK has received travel grants from Eli Lilly, Otsuka Pharmaceutical and is a speaker for Novartis and Otsuka Pharmaceutical. PE is an advisory board member with Amgen, MSD, and Eli Lilly and at the speaker’s bureau with Amgen and Eli Lilly, stocks from Novo Nordisk A/S. PV has received unrestricted grants from MSD and Servier, and travel grants from Amgen, Eli Lilly, Novartis, Sanofi-Aventis, and Servier.